Patent approved in China

During 2015 the patent  ”Method for detection of cytokeratin 8, 18 and/or 19 and/or soluble fragments thereof” was approved in Sweden. The patent has now been approved in China and is valid until 2034. Read more here

 

 Positive results for UBC® Rapid in an Austrian study

Read the news  here


 

IDL will participate at MEDICA, the world’s largest event for the medical sector. Medica is held 13-16 November, 2017, in  Düssseldorf, Germany. You will find us in Hall 3A, booth D28.

IDL will also participate in the Swedish Association of Urology in Gothenburg, Sweden October 4-6, 2017.

 

Positive results for UBC® Rapid

- UBC® Rapid is recommended to be added in the diagnostics of high grade bladder cancer tumours in a German multicenter study. Read more here 
- Positive results for UBC® Rapid in a Swedish multicenter study. Read more here

Oncology products

Cytokeratin Tumor markers

> TPS®

MonoTotal®

TPAcykTM

UBC®

Bacteriology products

Detection of acute typhoid fever

TUBEX® TF